Research Paper Volume 13, Issue 16 pp 20684—20697

Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD


Figure 5. Correlation between the LUAD 6-irlncRNA pair signature and immune cell subtype infiltration. (A) Estimation of the infiltrating immune cells by TIMER, CIBERSORT, xCELL, quanTIseq, MCPcounter, EPIC, and CIBERSORT-ABS. (BD) High-risk patients exhibited higher content of B cells (B), CD4+ T cells (C), and M2 macrophages (D) compared to the low-risk patients.